Suppr超能文献

胃型和肠型的导管内乳头状黏液性肿瘤的恶性潜能可能低于胰胆管型。

Intraductal papillary-mucinous neoplasms of the gastric and intestinal types may have less malignant potential than the pancreatobiliary type.

机构信息

Department of Gastroenterological, General, Breast and Thyroid Surgery, Faculty of Medicine, Yamagata University, Yamagata City, Japan.

出版信息

Pancreas. 2010 Jul;39(5):604-10. doi: 10.1097/MPA.0b013e3181c6947a.

Abstract

OBJECTIVES

Intraductal papillary-mucinous neoplasms (IPMNs) of the pancreas are classified into 4 types--gastric, intestinal, pancreatobiliary, and oncocytic--on the basis of their morphology and immunohistochemistry. We classified IPMNs at our institute and used this classification to determine the clinicopathological features, prognosis, and malignant potential of the 4 types.

METHODS

Sixty-one patients with IPMN who underwent surgery between 2000 and 2007 were evaluated retrospectively.

RESULTS

There were 24 tumors of the gastric type, 22 intestinal, 12 pancreatobiliary, and 3 oncocytic. Patients with the intestinal or gastric type had a better prognosis than those with the pancreatobiliary type. The intestinal and pancreatobiliary types had almost the same frequencies of carcinoma, but the intestinal type tended to have a lower frequency of invasive carcinoma than the pancreatobiliary type. Patients with invasive carcinomas derived from intestinal-type IPMNs tended to have a better prognosis than those whose invasive carcinomas were derived from the pancreatobiliary type.

CONCLUSIONS

Intraductal papillary-mucinous neoplasm of the gastric and intestinal types may have less malignant potential than that of the pancreatobiliary type. Invasive carcinomas derived from intestinal-type IPMNs may be less invasive and slower growing than those derived from the pancreatobiliary type.

摘要

目的

胰腺导管内乳头状黏液性肿瘤(IPMN)基于其形态学和免疫组织化学可分为胃型、肠型、胰胆管型和嗜酸细胞型 4 种类型。我们对本院的 IPMN 进行了分类,并使用该分类方法来确定 4 种类型的临床病理特征、预后和恶性潜能。

方法

回顾性分析 2000 年至 2007 年间手术治疗的 61 例 IPMN 患者。

结果

胃型肿瘤 24 例,肠型 22 例,胰胆管型 12 例,嗜酸细胞型 3 例。肠型或胃型患者的预后优于胰胆管型患者。肠型和胰胆管型的癌发生率几乎相同,但肠型的浸润性癌发生率低于胰胆管型。来源于肠型 IPMN 的浸润性癌患者的预后优于来源于胰胆管型的患者。

结论

胃型和肠型 IPMN 的恶性潜能可能低于胰胆管型。来源于肠型 IPMN 的浸润性癌可能比来源于胰胆管型的浸润性癌侵袭性更小、生长更慢。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验